NexGel, Inc Warrant closed at $0.01 on Sep 28, down 1.61%, 96.4% below its highest close since Dec 22. Volume of 9.3K shares was 1.09× its 20-day average (close to normal).
Split-adjusted performance: -32.2% over one month.
In the quarter ended Jun 30, 2026, revenue was $3.69M, up 27.8% from a year earlier, with a net margin of -98.6%.
Short interest was 1.3K shares at the Sep 15 settlement, down 81.6% from the prior report (1.0 days to cover).
No recent articles focused on NexGel, Inc Warrant. 2 articles mention it in passing.
Quick answers
What does NexGel, Inc Warrant do?
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies.
What is NXGLW's market cap?
$25.20K, based on the Sep 28 close of $0.01.
What sector is NXGLW in?
Healthcare, in the Surgical Instruments industry.
About NexGel, Inc Warrant
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
HQ: Langhorne, PA19 employeesListed Dec 17, 2021nexgel.com
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
